reporting season

CBA's valuation bubble is a symptom of the structural rise of passive investing that has changed how active managers impact market prices.

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.

Rapid Fire interview with the Yarra Capital Management equities team following the recently completed ASX reporting season.

The Yarra Capital Management equities team take a deep dive into big themes, key sectors, and compelling stock opportunities.

Read on to find the ratings, consensus price targets, and FNArena insights on each stock covered.

SGH Ltd (SGH) CEO, Ryan Stokes speaks with Tom Piotrowski about the company’s dividend policy and its half year results.

Qantas (ASX: QAN) has posted a significant rise in half-year profits, demonstrating continued momentum in the airline’s post-pandemic recovery. The company reported an...

With the ink from CEO signatures still drying on earnings reports, James Gerrish & Jun Bei Liu give their hot take on key themes and stocks

Telstra’s (ASX:TLS) latest half-year financial results, released yesterday, tell a story of modest gains, underpinned by cost control rather than broad-based...

Look past the headline loss and focus on the underlying improvements, and there's plenty to like about TCL's results, says Ofer Karliner.

Wesfarmers shares eyed a record high on Thursday, but it needs a big acquisition to justify its valuation, said Martin Currie's Jim Power.

We sat down with HUB24 CEO, Andrew Alcock on results day to discuss the past six months and the all-important outlook.

CSL (ASX:CSL) has posted its half-year results, delivering results that are best described as mixed. At the headline level, revenue climbed around five per cent, while...

We sat down with Pro Medicus CEO, Dr Sam Hupert on results day to discuss the past six months and the all-important outlook.

The largest position in The Montgomery Fund portfolio, at almost eight per cent of the portfolio, is the Commonwealth Bank of Australia (ASX:CBA), purchased back when...

We've put together the quintessential reporting season guide as we head into Feburary reporting season.

ResMed’s (ASX:RMD) half-year FY25 results reflect a company that is not only thriving in its core business but is also strategically positioned to capitalise on future...

Livewire sat down with Life360's CEO and co-founder Chris Hulls for an exclusive conversation on the company's outlook.

Medallion Financial's Michael Wayne and First Sentier Investors' David Wilson discuss the highs and lows of the results season.

Livewire sits down with Katana Asset Management's Romano Sala Tenna to find out.